Deals channel feed – Endpoints News

Deals channel feed

Nestlé puts down $40M, kicks off deal with gut microbiome specialist to fight food allergies

3 years ago

After initial commercial foray, China's CStone mulls sale — report

3 years ago

Bayer sells testosterone treatment to German company for $500M

3 years ago

Ultragenyx sells $500M in royalty interest on rare disease drug to Canadian pension plan

3 years ago

Theravance, Innoviva sell royalty rights on GSK's Trelegy to Royalty Pharma for $1.3B upfront

3 years ago

Illumina loses challenge to block EU antitrust probe into $8B Grail buyout

3 years ago

Novo Nordisk nabs priority review voucher for $110M from Marinus as the biotech preps first drug launch

3 years ago

Sanofi CEO Paul Hudson offloads two portfolios to German pharma company in continued effort to prune products

3 years ago

TherapeuticsMD shares crater as anticipated M&A deal falls through

3 years ago

With eyes on Keytruda patent cliff, Merck takes a $290M swing at prostate cancer

3 years ago

Faheem Hasnain forges a $120M private placement. So what did we learn from that?

3 years ago

How interest in a single cancer drug led to Ipsen's takeover of Epizyme

3 years ago

No surrender: A group of marquee biotech players bets on the $350M PhIII resurrection story of a heavyweight contender

3 years ago

Emergent nets another manufacturing deal, this time for Ridgeback's Ebola treatment

3 years ago

Vertex nabs ViaCyte's rival diabetes stem cell treatment, acquiring the biotech for $320M in cash

3 years ago

Ionis hands off an antisense drug for kidney disease, giving all rights to Roche

3 years ago

La Jolla exits to Innoviva in a deal that caps 33 years marked by misses in lupus, malaria and beta thalassemia

3 years ago

Sinopharm mulls $1B buyout of China-based DNA synthesis company — report

3 years ago

Korean diagnostics biotech goes transpacific, agreeing to shell out $1.5B to take Meridian private

3 years ago

A portrait of a biotech buyout deal in savage times: turning a $15.50 offer into a $7.12 deal

3 years ago

AbbVie dumps an early-stage drug in $225M Alzheimer's alliance with Alector

3 years ago

Ameet Mallik wraps a $435M commercial deal shortly after taking helm at ADC

3 years ago

European manufacturer Fagron expands its US presence by acquiring a facility on the East Coast

3 years ago

Fresh report of 'advanced' $40B+ Seagen buyout talks spurs more buzz about FTC showdown

3 years ago

First page Previous page 54 55 565758 59 60 Next page Last page